OncoCyte Corp (OCX)
2.76
+0.19
(+7.39%)
USD |
NASDAQ |
May 02, 16:00
2.76
0.00 (0.00%)
After-Hours: 20:00
OncoCyte Total Liabilities (Quarterly): 54.42M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 54.42M |
| September 30, 2023 | 44.02M |
| June 30, 2023 | 43.94M |
| March 31, 2023 | 44.87M |
| December 31, 2022 | 65.80M |
| September 30, 2022 | 80.49M |
| June 30, 2022 | 82.95M |
| March 31, 2022 | 89.31M |
| December 31, 2021 | 94.35M |
| September 30, 2021 | 68.99M |
| June 30, 2021 | 74.72M |
| March 31, 2021 | 22.68M |
| December 31, 2020 | 21.94M |
| September 30, 2020 | 23.14M |
| June 30, 2020 | 23.86M |
| March 31, 2020 | 22.88M |
| December 31, 2019 | 9.021M |
| September 30, 2019 | 3.435M |
| Date | Value |
|---|---|
| June 30, 2019 | 4.161M |
| March 31, 2019 | 3.49M |
| December 31, 2018 | 6.095M |
| September 30, 2018 | 5.382M |
| June 30, 2018 | 5.35M |
| March 31, 2018 | 6.56M |
| December 31, 2017 | 5.813M |
| September 30, 2017 | 6.201M |
| June 30, 2017 | 6.502M |
| March 31, 2017 | 6.401M |
| December 31, 2016 | 4.585M |
| September 30, 2016 | 4.179M |
| June 30, 2016 | 2.957M |
| March 31, 2016 | 2.752M |
| December 31, 2015 | 2.314M |
| September 30, 2015 | 5.356M |
| December 31, 2014 | 6.315M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.435M
Minimum
Sep 2019
94.35M
Maximum
Dec 2021
46.05M
Average
44.02M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| Fonar Corp | 45.96M |
| XWELL Inc | 18.02M |
| ProPhase Labs Inc | 42.54M |
| Applied DNA Sciences Inc | 5.785M |
| Veracyte Inc | 70.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 74.89M |
| Shareholders Equity (Quarterly) | 20.47M |
| Current Ratio | 1.487 |